Immix Biopharma (IMMX) Stock Chart & Stock Price History → Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad) Free IMMX Stock Alerts $2.35 +0.15 (+6.82%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immix Biopharma Stock Price Performance5 Day Performance+7.80%1 Month Performance-8.56%3 Month Performance-26.33%6 Month Performance-47.19%Year-To-Date Performance-66.04%1 Year Performance+27.03% Receive IMMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects IMMX Stock Chart for Thursday, May, 16, 2024 IMMX Chart by TradingView Immix Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$2.20$2.35+6.82%$2.44$2.22132,169 shs$62.06 million05/14/2024$2.16$2.20+1.85%$2.30$2.1391,323 shs$58.10 million05/13/2024$2.18$2.16-0.92%$2.22$2.1379,427 shs$57.05 million05/10/2024$2.18$2.18$2.30$1.95403,546 shs$57.56 million05/09/2024$2.24$2.18-2.68%$2.28$2.11124,441 shs$57.56 million05/08/2024$2.21$2.24+1.36%$2.30$2.1463,425 shs$59.15 million Get the Latest News and Ratings for IMMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$2.33$2.21-5.15%$2.33$2.1571,983 shs$58.35 million05/06/2024$2.35$2.33-0.85%$2.50$2.26128,381 shs$61.51 million05/03/2024$2.31$2.35+1.73%$2.51$2.31112,884 shs$62.04 million05/02/2024$2.17$2.31+6.45%$2.37$2.1188,130 shs$60.99 million05/01/2024$2.17$2.17$2.25$2.0855,808 shs$57.29 million04/30/2024$2.12$2.17+2.36%$2.33$2.04107,287 shs$57.29 million04/29/2024$2.13$2.12-0.47%$2.40$2.03227,470 shs$55.97 million04/26/2024$2.10$2.13+1.43%$2.25$2.0584,843 shs$56.23 million04/25/2024$2.13$2.10-1.41%$2.29$2.0283,185 shs$55.44 million04/24/2024$2.30$2.13-7.39%$2.31$2.1059,773 shs$56.23 million04/23/2024$2.13$2.30+7.98%$2.35$2.0879,945 shs$60.71 million04/22/2024$2.19$2.13-2.74%$2.21$1.94191,294 shs$56.23 million04/19/2024$2.21$2.19-0.90%$2.33$2.1863,953 shs$57.82 million04/18/2024$2.50$2.21-11.60%$2.55$2.20189,335 shs$58.34 million04/17/2024$2.57$2.50-2.72%$2.73$2.04515,985 shs$66 million04/16/2024$2.66$2.57-3.38%$2.68$2.53238,799 shs$67.85 million04/15/2024$2.76$2.66-3.62%$2.84$2.6595,242 shs$70.22 million04/12/2024$2.89$2.76-4.50%$2.88$2.63134,028 shs$72.86 million04/11/2024$2.88$2.89+0.35%$2.93$2.73119,250 shs$76.30 million04/10/2024$2.84$2.88+1.41%$2.90$2.73112,467 shs$76.03 million04/09/2024$2.86$2.84-0.70%$2.95$2.79213,225 shs$74.97 million04/08/2024$2.87$2.86-0.35%$2.99$2.63102,171 shs$75.50 million04/05/2024$2.81$2.87+2.14%$2.94$2.7072,331 shs$57.03 million04/04/2024$3.06$2.81-8.17%$3.06$2.74161,319 shs$55.83 million04/03/2024$2.94$3.06+4.08%$3.13$2.8788,624 shs$60.80 million04/02/2024$2.92$2.94+0.68%$3.02$2.7848,361 shs$58.42 million04/01/2024$3.07$2.92-4.89%$3.10$2.73281,314 shs$58.02 million03/29/2024$3.07$3.07$3.23$3.0094,564 shs$60.99 million03/28/2024$3.07$3.07$3.23$3.0094,564 shs$61.00 million03/27/2024$2.94$3.07+4.42%$3.16$3.0048,934 shs$61.00 million03/26/2024$3.19$2.94-7.84%$3.19$2.87104,028 shs$58.42 million03/25/2024$3.29$3.19-3.04%$3.35$3.06118,345 shs$63.39 million03/22/2024$3.04$3.29+8.22%$3.30$3.01199,521 shs$65.37 million03/21/2024$2.74$3.04+10.95%$3.21$2.71207,505 shs$60.41 millionThis is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects03/20/2024$2.76$2.74-0.72%$2.95$2.65130,881 shs$54.44 million03/19/2024$2.70$2.76+2.22%$2.81$2.58105,483 shs$54.83 million03/18/2024$2.64$2.70+2.27%$2.74$2.53195,235 shs$53.65 million03/15/2024$2.84$2.64-7.04%$2.90$2.57458,547 shs$52.46 million03/14/2024$3.08$2.84-7.79%$3.11$2.79282,393 shs$56.42 million03/13/2024$3.10$3.08-0.65%$3.19$3.0379,967 shs$61.20 million03/12/2024$3.08$3.10+0.65%$3.24$3.02129,132 shs$61.60 million03/11/2024$3.23$3.08-4.64%$3.21$2.92175,857 shs$61.20 million03/08/2024$3.38$3.23-4.44%$3.48$3.17199,417 shs$64.18 million03/07/2024$3.38$3.38$3.48$3.35152,076 shs$67.16 million03/06/2024$3.31$3.38+2.11%$3.42$3.24284,394 shs$67.16 million03/05/2024$3.60$3.31-8.06%$3.64$3.27162,073 shs$65.76 million03/04/2024$3.50$3.60+2.86%$3.74$3.46158,248 shs$71.53 million03/01/2024$3.35$3.50+4.48%$3.71$3.36247,277 shs$69.55 million02/29/2024$3.70$3.35-9.46%$3.80$3.32352,656 shs$66.56 million02/28/2024$3.26$3.70+13.50%$3.77$3.23717,520 shs$73.52 million02/27/2024$3.02$3.26+7.95%$3.27$2.99395,416 shs$64.78 million02/26/2024$3.04$3.02-0.66%$3.06$2.94144,340 shs$60.01 million02/23/2024$3.06$3.04-0.65%$3.24$3.0288,351 shs$60.41 million02/22/2024$2.99$3.06+2.34%$3.25$2.92208,342 shs$60.80 million02/21/2024$2.99$2.99$3.05$2.86310,432 shs$59.41 million02/20/2024$3.19$2.99-6.27%$3.29$2.96340,709 shs$59.40 million02/19/2024$3.19$3.19$3.28$2.90343,100 shs$63.39 million02/16/2024$2.91$3.19+9.62%$3.28$2.90343,190 shs$63.39 million02/15/2024$2.77$2.91+5.05%$2.95$2.71264,597 shs$57.81 million Related Companies: Annovis Bio Stock Chart Reneo Pharmaceuticals Stock Chart Celularity Stock Chart CalciMedica Stock Chart AEON Biopharma Stock Chart Checkpoint Therapeutics Stock Chart Eledon Pharmaceuticals Stock Chart Kezar Life Sciences Stock Chart Eagle Pharmaceuticals Stock Chart BioLineRx Stock Chart Receive IMMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMMX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.